• Citer

Low residual proliferation after short-term letrozole therapy is an early predictive marker of response in high proliferative ER-positive breast cancer.

par Bedard, Philippe L;Singhal, Sandeep K;Ignatiadis, Michail ;Bradbury, Ian;Haibe-Kains, Benjamin ;Desmedt, Christine ;Loi, Sherene ;Evans, Dean B;Michiels, Stefan ;Dixon, J Michael;Miller, William R;Piccart-Gebhart, Martine ;Sotiriou, Christos
Référence Endocrine-related cancer, 18, 6, page (721-730)
Publication Publié, 2011-10

Article révisé par les pairs

• Accès en ligne
• Détails
• Contenu
• Statistiques

Titre:	Low residual proliferation after short-term letrozole therapy is an early predictive marker of response in high proliferative ER-positive breast cancer.
Auteur:	Bedard, Philippe L; Singhal, Sandeep K; Ignatiadis, Michail; Bradbury, Ian; Haibe-Kains, Benjamin; Desmedt, Christine; Loi, Sherene; Evans, Dean B; Michiels, Stefan; Dixon, J Michael; Miller, William R; Piccart-Gebhart, Martine; Sotiriou, Christos
Informations sur la publication:	Endocrine-related cancer, 18, 6, page (721-730)
Statut de publication:	Publié, 2011-10
Sujet CREF:	Cancérologie
Note générale:	Journal Article
	Research Support, Non-U.S. Gov't
	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:1351-0088
	info:doi/10.1530/ERC-11-0180
	info:pii/ERC-11-0180
	info:scp/84855916374
	info:pmid/21984694